Compound Profile: SR9009 (STENABOLIC) Pharmaqo
SR-9009 (Stenabolic) is a Rev-Erbα nuclear receptor agonist developed for metabolic research applications. This synthetic compound modulates circadian rhythm gene expression pathways and demonstrates effects on mitochondrial biogenesis in murine models. Unlike SARMs, SR-9009 functions through Rev-Erbα receptor activation rather than androgen receptor modulation. Research laboratories investigating metabolic syndrome and circadian biology utilise this compound to examine cellular energy expenditure mechanisms. Studies indicate SR-9009 influences lipid metabolism pathways, though oral bioavailability limitations have been documented in preclinical models. Researchers at Stroid UK Shop frequently procure this compound for metabolic pathway investigations.
Scientific Applications
Laboratory studies examine SR-9009’s role in Rev-Erbα-mediated metabolic regulation. Research applications focus on circadian rhythm disruption models and mitochondrial function analysis. The compound demonstrates tissue-specific effects on fatty acid oxidation pathways in adipose tissue research. Scientists studying metabolic dysfunction utilise SR-9009 to investigate cellular energy balance mechanisms. Published research examines its effects on gluconeogenesis and lipogenesis pathways in hepatic cell culture models. Comparative studies with other metabolic modulators available through our Stenabolic research collection provide comprehensive pathway analysis. Research groups investigating obesity models examine SR-9009’s effects on adipocyte metabolism and thermogenesis. Laboratory protocols typically compare SR-9009 with established compounds from our SARM research catalogue and complementary research tools from our peptide research division for comprehensive metabolic studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | SR-9009 (Stenabolic) |
| CAS Number | 1379686-30-2 |
| Molecular Formula | C₂₀H₂₄ClN₃O₄S |
| Molecular Weight | 437.94 g/mol |
| Mechanism | Rev-Erbα nuclear receptor agonist |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Pharmaqo Labs |
| Research Applications | Metabolic pathway studies, circadian research |
Compliance Statement
This SR-9009 compound is manufactured exclusively for in-vitro research purposes and laboratory analysis. Not approved for human consumption, therapeutic use, or clinical applications. Research institutions must ensure appropriate handling protocols and regulatory compliance. Storage recommendations include room temperature maintenance in dry conditions away from direct light exposure. All research applications must conform to institutional guidelines and applicable legislation governing research chemical usage.
